Staphylococcal innate immune evasion

Trends in Microbiology

Volumn 13, Issue 12, 2005, Pages 596-601

  Rooijakkers, Suzan H M ^a   Van Kessel, Kok P M ^a   Van Strijp, Jos A G ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CATHELICIDIN; CELL RECEPTOR; COMPLEMENT COMPONENT C5A; COMPLEMENT FACTOR H; DEFENSIN; PEPTIDE; PROTEIN A; REACTIVE OXYGEN METABOLITE; SUPERANTIGEN; VIRULENCE FACTOR;

CELL MIGRATION; COMPLEMENT SYSTEM; DEFENSE MECHANISM; EXCRETION; HUMAN; IMMUNE SYSTEM; INNATE IMMUNITY; NEUTROPHIL; NONHUMAN; PHAGOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS; VIRULENCE;

HUMANS; IMMUNITY, NATURAL; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; VIRULENCE FACTORS;

STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS;

EID: 27844537795     PISSN: 0966842X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tim.2005.10.002     Document Type: Review

References (43)

1. J. Verhoef Staphylococci and other micrococci J. Cohen W.G. Powderly Infectious Disease 2004 Elsevier (Mosby) 2119 2132
2. J. Projan, and R. Novick The molecular basis of pathogenicity K.B. Grossley G.L. Archer The Staphylococci in Human Disease 1997 Churchill Livingstone 55 81
3. S. Ram The contrasting mechanisms of serum resistance of Neisseria gonorrhoeae and group B Neisseria meningitidis Mol. Immunol. 36 1999 915 928
4. R. Wurzner Evasion of pathogens by avoiding recognition or eradication by complement, in part via molecular mimicry Mol. Immunol. 36 1999 249 260
5. H. Jarva Complement resistance mechanisms of streptococci Mol. Immunol. 40 2003 95 107
6. P. Kraiczy, and R. Wurzner Complement escape of human pathogenic bacteria by acquisition of complement regulators Mol. Immunol. 43 2006 31 44
7. B. Beutler Innate immunity: an overview Mol. Immunol. 40 2004 845 859
8. K. Takeda, and S. Akira Toll-like receptors in innate immunity Int. Immunol. 17 2005 1 14
9. H. Steiner Peptidoglycan recognition proteins: on and off switches for innate immunity Immunol. Rev. 198 2004 83 96
10. C.A. Muller Intestinal epithelial barrier and mucosal immunity innate defenses of the intestinal epithelial barrier Cell. Mol. Life Sci. 62 2005 1297 1307
11. A. Peschel How do bacteria resist human antimicrobial peptides? Trends Microbiol. 10 2002 179 186
12. A. Sahu, and J.D. Lambris Structure and biology of complement protein C3, a connecting link between innate and acquired immunity Immunol. Rev. 180 2001 35 48
13. P. Gasque Complement: a unique innate immune sensor for danger signals Mol. Immunol. 41 2004 1089 1098
14. D. Roos Oxidative killing of microbes by neutrophils Microbes Infect. 5 2003 1307 1315
15. A. Mayer-Scholl How do neutrophils and pathogens interact? Curr. Opin. Microbiol. 7 2004 62 66
16. N.W. Schroder Lipoteichoic acid (LTA) of Streptococcus pneumoniae and Staphylococcus aureus activates immune cells via Toll-like receptor (TLR)-2, lipopolysaccharide-binding protein (LBP), and CD14, whereas TLR-4 and MD-2 are not involved J. Biol. Chem. 278 2003 15587 15594
17. C.J. De Haas Chemotaxis inhibitory protein of Staphylococcus aureus, a bacterial antiinflammatory agent J. Exp. Med. 199 2004 687 695
18. N.J. Lynch L-Ficolin specifically binds to lipoteichoic acid, a cell wall constituent of Gram-positive bacteria, and activates the lectin pathway of complement J. Immunol. 172 2004 1198 1202
19. O. Neth Enhancement of complement activation and opsonophagocytosis by complexes of mannose-binding lectin with mannose-binding lectin-associated serine protease after binding to Staphylococcus aureus J. Immunol. 169 2002 4430 4436
20. U. Wirthmueller Receptor-operated activation of polymorphonuclear leukocytes: different effects of NAP-1/IL-8 and fMet-Leu-Phe or C5a Biochem. Biophys. Res. Commun. 176 1991 972 978
21. W. Zimmerli The role of formylpeptide receptors, C5a receptors and cytosolic-free calcium in neutrophil priming J. Infect. Dis. 161 1990 242 249
22. T. Jin Staphylococcus aureus resists human defensins by production of staphylokinase, a novel bacterial evasion mechanism J. Immunol. 172 2004 1169 1176
23. M. Sieprawska-Lupa Degradation of human antimicrobial peptide LL-37 by Staphylococcus aureus-derived proteinases Antimicrob. Agents Chemother. 48 2004 4673 4679
24. A. Bera Why are pathogenic staphylococci so lysozyme resistant? The peptidoglycan O-acetyltransferase OatA is the major determinant for lysozyme resistance of Staphylococcus aureus Mol. Microbiol. 55 2005 778 787
25. G.Y. Liu Staphylococcus aureus golden pigment impairs neutrophil killing and promotes virulence through its antioxidant activity J. Exp. Med. 202 2005 209 215
26. M.I. Gomez Staphylococcus aureus protein A induces airway epithelial inflammatory responses by activating TNFR1 Nat. Med. 10 2004 842 848
27. S.H.M. Rooijakkers Anti-opsonic properties of staphylokinase Microbes Infect. 7 2005 476 484
28. L.Y. Lee Inhibition of complement activation by a secreted Staphylococcus aureus protein J. Infect. Dis. 190 2004 571 579
29. L.Y. Lee Identification and characterization of the C3 binding domain of the Staphylococcus aureus extracellular fibrinogen-binding protein (Efb) J. Biol. Chem. 279 2004 50710 50716
30. P.F. Zipfel Factor H family proteins: on complement, microbes and human diseases Biochem. Soc. Trans. 30 2002 971 978
31. H. Jiang, and M.M. Frank Staphylococcus binds to factor H and H-related proteins Molecular Immunol. 41 2004 252 (Abstract #112)
32. K.E. Veldkamp Modulation of neutrophil chemokine receptors by Staphylococcus aureus supernate Infect. Immun. 68 2000 5908 5913
33. B. Postma Chemotaxis inhibitory protein of Staphylococcus aureus binds specifically to the C5a and formylated peptide receptor J. Immunol. 172 2004 6994 7001
34. P.J. Haas N-terminal residues of the chemotaxis inhibitory protein of Staphylococcus aureus are essential for blocking formylated peptide receptor but not C5a receptor J. Immunol. 173 2004 5704 5711
35. B. Postma Residues 10-18 within the C5a receptor N terminus compose a binding domain for chemotaxis inhibitory protein of Staphylococcus aureus J. Biol. Chem. 280 2005 2020 2027
36. S.H.M. Rooijakkers Immune evasion by a staphylococcal complement inhibitor that acts on C3 convertases Nat. Immunol. 6 2005 920 927
37. R. Langley The staphylococcal superantigen-like protein 7 binds IgA and complement C5 and inhibits IgA-Fc alpha RI binding and serum killing of bacteria J. Immunol. 174 2005 2926 2933
38. T. Chavakis Staphylococcus aureus extracellular adherence protein serves as anti-inflammatory factor by inhibiting the recruitment of host leukocytes Nat. Med. 8 2002 687 693
39. A. Haggar The extracellular adherence protein from Staphylococcus aureus inhibits neutrophil binding to endothelial cells Infect. Immun. 72 2004 6164 6167
40. B.V. Geisbrecht The crystal structures of EAP domains from Staphylococcus aureus reveal an unexpected homology to bacterial superantigens J. Biol. Chem. 280 2005 17243 17250
41. R. Rahimpour Bacterial superantigens induce down-modulation of CC chemokine responsiveness in human monocytes via an alternative chemokine ligand-independent mechanism J. Immunol. 162 1999 2299 2307
42. A. Alcami Viral mimicry of cytokines, chemokines and their receptors Nat. Rev. Immunol. 3 2003 36 50
43. P.G. Stevenson Immune evasion by gamma-herpesviruses Curr. Opin. Immunol. 16 2004 456 462